Clinical Trial Update: A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dosing of AMG 827 for inadequately controlled asthma has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AMG 827

Snippet

Sponsor: Amgen | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2021-11-26